188 related articles for article (PubMed ID: 23970818)
1. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Cynkier A; Sysa-Jedrzejowska A; Waszczykowska E
Mediators Inflamm; 2013; 2013():967987. PubMed ID: 23970818
[TBL] [Abstract][Full Text] [Related]
2. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
[TBL] [Abstract][Full Text] [Related]
3. Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska-Kanicka O; Kulczycka-Siennicka L; Wozniacka A; Waszczykowska E
Mediators Inflamm; 2014; 2014():936545. PubMed ID: 25400334
[TBL] [Abstract][Full Text] [Related]
4. Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases.
Żebrowska A; Woźniacka A; Juczyńska K; Ociepa K; Waszczykowska E; Szymczak I; Pawliczak R
Mediators Inflamm; 2017; 2017():8980534. PubMed ID: 28611508
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis.
Antiga E; Quaglino P; Pierini I; Volpi W; Lami G; Bianchi B; Del Bianco E; Renzi D; Baroni G; Novelli M; Ponti R; Papini M; Di Lollo S; Calabrò AS; Fabbri P; Caproni M
J Dermatol Sci; 2015 Jan; 77(1):54-62. PubMed ID: 25465638
[TBL] [Abstract][Full Text] [Related]
6. Expression of selected adhesion molecules in dermatitis herpetiformis and bullous pemphigoid.
Zebrowska A; Waszczykowska E; Wagrowska-Danilewicz M; Danilewicz M; Erkiert-Polguj A; Pawliczak R; Sysa-Jedrzejowska A
Pol J Pathol; 2009; 60(1):26-34. PubMed ID: 19670701
[TBL] [Abstract][Full Text] [Related]
7. Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.
Juczynska K; Wozniacka A; Waszczykowska E; Danilewicz M; Wagrowska-Danilewicz M; Wieczfinska J; Pawliczak R; Zebrowska A
Mediators Inflamm; 2017; 2017():6716419. PubMed ID: 29203970
[TBL] [Abstract][Full Text] [Related]
8. Expression of selected neuropeptides in pathogenesis of bullous pemphigoid and dermatitis herpetiformis.
Cynkier A; Zebrowska A; Wągrowska-Danilewicz M; Danilewicz M; Erkiert-Polguj A; Stasikowska-Kanicka O; Sysa-Jędrzejowska A; Waszczykowska E
Pol J Pathol; 2012 Mar; 63(1):31-9. PubMed ID: 22535604
[TBL] [Abstract][Full Text] [Related]
9. The role of apoptosis in the pathogenesis of dermatitis herpetiformis.
Caproni M; Torchia D; Antiga E; Degl'Innocenti D; Barletta E; Baroni G; Santucci M; Fabbri P
Int J Immunopathol Pharmacol; 2005; 18(4):691-9. PubMed ID: 16388717
[TBL] [Abstract][Full Text] [Related]
10. [Expression of transient receptor potential lvanilloidreceptor 4 protein in autoimmune bullous skin disorders].
Bai J; Zou X; Jiang Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1349-51. PubMed ID: 26403753
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
Nätynki A; Tuusa J; Hervonen K; Kaukinen K; Lindgren O; Huilaja L; Kokkonen N; Salmi T; Tasanen K
Front Immunol; 2020; 11():575805. PubMed ID: 33072118
[TBL] [Abstract][Full Text] [Related]
12. Expression of selected ADAMs in bullous pemphigoid and dermatitis herpetiformis.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wodz K; Sokolowska M; Erkiert-Polguj A; Sysa-Jedrzejowska A; Waszczykowska E; Pawliczak R
J Dermatol Sci; 2009 Oct; 56(1):58-61. PubMed ID: 19695840
[No Abstract] [Full Text] [Related]
13. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.
Le Jan S; Plée J; Vallerand D; Dupont A; Delanez E; Durlach A; Jackson PL; Edwin Blalock J; Bernard P; Antonicelli F
J Invest Dermatol; 2014 Dec; 134(12):2908-2917. PubMed ID: 24945093
[TBL] [Abstract][Full Text] [Related]
14. Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases.
Bornscheuer E; Zillikens D; Schröder JM; Sticherling M
Dermatology; 1999; 198(2):118-21. PubMed ID: 10325455
[TBL] [Abstract][Full Text] [Related]
15. Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.
Marzano AV; Tedeschi A; Berti E; Fanoni D; Crosti C; Cugno M
Clin Exp Immunol; 2011 Jul; 165(1):44-50. PubMed ID: 21488867
[TBL] [Abstract][Full Text] [Related]
16. Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid.
Bonciani D; Quintarelli L; Del Bianco E; Bianchi B; Caproni M
J Dermatol Sci; 2017 Aug; 87(2):210-212. PubMed ID: 28465041
[No Abstract] [Full Text] [Related]
17. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-L-like cytokines in Dermatitis herpetiformis.
Caproni M; Cardinali C; D'Agata A; Selvaggi W; Fabbri P
Int Arch Allergy Immunol; 2002 May; 128(1):67-72. PubMed ID: 12037403
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis.
Gornowicz-Porowska J; Bowszyc-Dmochowska M; Dmochowski M
Autoimmunity; 2012 Feb; 45(1):71-80. PubMed ID: 21916544
[TBL] [Abstract][Full Text] [Related]
19. NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
Giusti D; Bini E; Terryn C; Didier K; Le Jan S; Gatouillat G; Durlach A; Nesmond S; Muller C; Bernard P; Antonicelli F; Pham BN
Front Immunol; 2019; 10():701. PubMed ID: 31019514
[No Abstract] [Full Text] [Related]
20. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid.
Oikarinen AI; Zone JJ; Ahmed AR; Kiistala U; Uitto J
J Invest Dermatol; 1983 Sep; 81(3):261-6. PubMed ID: 6309988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]